The Cancer Predisposition Program at St. Louis Children’s Hospital, led by Dr. Todd Druley, has published a systematic review finding that pediatric cancer risk increases in association with birth defects. Notably, there is a strong, consistent association with CNS abnormalities and the incidence of CNS cancers. With novel high-throughput technologies, we may be able to find the […]
Dr. Druley discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA.
Todd E. Druley, MD, from the Washington University School of Medicine in St. Louis, St. Louis, MO, discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA. He explains that minimal residual disease (MRD) is the assessment for residual leukemia after a patient […]
Kellsie’s Hope Foundation sponsored their 5th annual Trees of Hope Gala on November 19th in memory of Kellsie Marchbanks (a former patient of Dr. Druleys) and so many other children who have lost their fight with cancer. The Druley lab was well represented and incredibly honored to receive a donation of $100,000 to support their […]
Dr. Druley is a pediatric oncologist who is focused on the genetic causes of cancer in children and is most rewarded by helping both families and patients through treatment.